Your browser doesn't support javascript.
loading
Cytokine clusters as potential diagnostic markers of disease activity and renal involvement in systemic lupus erythematosus.
Park, Joonhong; Jang, Woori; Park, Hye Sun; Park, Ki Hyun; Kwok, Seung-Ki; Park, Sung-Hwan; Oh, Eun-Jee.
Afiliación
  • Park J; Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Jang W; Department of Laboratory Medicine, Inha University School of Medicine, Incheon, Korea.
  • Park HS; Department of Biomedical Science & Health Sciences, Graduate School, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Park KH; Department of Biomedical Science & Health Sciences, Graduate School, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kwok SK; Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Park SH; Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Oh EJ; Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
J Int Med Res ; 48(6): 300060520926882, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32489126
ABSTRACT

OBJECTIVE:

To describe interactions among cytokines and to identify subgroups of systemic lupus erythematosus (SLE) patients based on cytokine levels using principal component analysis and cluster analysis.

METHODS:

Levels of 12 cytokines were measured using sensitive multiplex bead assays and associations with SLE features including disease activity and renal involvement were assessed.

RESULTS:

In a group of 203 SLE patients, strong correlations were observed between interleukin (IL)6 and interferon (IFN)γ levels (r = 0.624), IL17 and IFNγ levels (r = 0.768), and macrophage inflammatory protein (MIP)1α and MIP1ß levels (r = 0.675). Cluster analysis revealed two distinct patient groups characterized by high levels of IL8, MIP1α, and MIP1ß (group 1) or of IL2, IL6, IL10, IL12, IFNγ, and tumor necrosis factor α (group 2). Active disease was more common in group 1 (49/88, 55.7%) than in group 2 (40/115, 34.8%). More patients in group 2 had renal involvement (42/115, 36.5%) than in group 1 (22/88, 25%).

CONCLUSIONS:

Assessment of cytokine profiles can identify distinct SLE patient subgroups and aid in understanding clinical heterogeneity and immunological phenotypes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Nefritis Lúpica / Citocinas / Lupus Eritematoso Sistémico Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: J Int Med Res Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Nefritis Lúpica / Citocinas / Lupus Eritematoso Sistémico Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Revista: J Int Med Res Año: 2020 Tipo del documento: Article